Sun Pharmaceuticals has been shining so far this year. But regulatory headwinds have caused the drugmaker’s shares to pullback from the former highs in recent weeks. Here’s why the stock may now be a compelling long-term buy.
Sun Pharmaceuticals has been shining so far this year. But regulatory headwinds have caused the drugmaker’s shares to pullback from the former highs in recent weeks. Here’s why the stock may now be a compelling long-term buy.